Incyte in United Kingdom
![](https://ichgcp.net/storage/uploads/pharma-list/logo/incyte_logo.png?v=1670532314)
E-mail: UK_enquiries@incyte.com
Web: https://incytebiosciences.uk/
Address:
-
Incyte Biosciences UK Ltd
First Floor Q1, The Square, Randalls Way, Leatherhead, UK, KT22 7TW
Phone: +44 800 783 3711
Fax: +44 800 066 9105
Other Incyte's locations around the world
Clinical Trials sponsored by Incyte
-
Incyte Biosciences Japan GK募集
-
Incyte Biosciences International Sàrl完了
-
Incyte Biosciences International Sàrl終了しました
-
Incyte Biosciences International Sàrl完了子宮頸癌 | 肝細胞癌 | 食道がん | 卵巣がん | 中皮腫 | 非小細胞肺がん (NSCLC) | 尿路上皮がん | メルケル細胞がん | びまん性大細胞型B細胞リンパ腫 | トリプルネガティブ乳がん | 腎細胞がん(RCC) | 小細胞肺がん(SCLC) | 頭頸部の扁平上皮癌(SCCHN) | マイクロサテライト不安定性 (MSI) - 高子宮内膜がん | 胃がん(胃および胃食道接合部[GEJ]を含む) | 黒色腫(ぶどう膜黒色腫を除く) | MSI-highの結腸直腸がんアメリカ
-
Incyte Biosciences International Sàrl引きこもった
-
Incyte Biosciences Benelux完了慢性骨髄性白血病 | CML | フィラデルフィア染色体陽性の急性リンパ芽球性白血病 | Ph+ すべてベルギー
-
Incyte Corporationまだ募集していません
-
Incyte Corporation募集化膿性汗腺炎(HS)アメリカ, オーストリア, ベルギー, ドイツ, ポーランド, スペイン, オーストラリア, デンマーク, フランス, イギリス, カナダ, 日本, ブルガリア, オランダ, チェコ, ギリシャ, イタリア
About Incyte
Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Our drug discovery and development efforts were founded in 2002 in Wilmington, Delaware, by a team of research scientists, chemists and biologists working in immunology. Today, we employ approximately 1500 people and have operations in the U.S., Europe and Japan. Our unique expertise in medicinal chemistry and biology have enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing pipeline of medicines across two franchises: Oncology and Inflammation & Autoimmunity. The commitment of our talented team of world-class scientists to continued scientific excellence has enabled us to identify new molecules, decipher new pathways and develop first-in-class and best-in-class medicines.